Acacia director sells 33,000 shares at $4.6

ACACIA RESEARCH CORP (ACTG) director Maureen O'Connell reported selling a total of 33,000 shares of ACTG common stock in open market or private transactions.

Rhea-AI Filing Summary

ACACIA RESEARCH CORP (ACTG) director Maureen O'Connell reported selling a total of 33,000 shares of ACTG common stock in open market or private transactions. On September 2, 2026, she sold 20,534 shares at a weighted average price of $4.63 per share, in multiple trades between $4.615 and $4.645. On September 3, 2026, she sold 12,466 shares at a weighted average price of $4.57 per share, in multiple trades between $4.51 and $4.66. No Rule 10b5-1 trading plan is reported, and post-transaction share holdings are not stated.

Insider Trade Summary

Net Seller: 33,000 shares

Net Sell 2 txns

Insider OCONNELL MAUREEN

Role Director

Sold 33,000 shs ($152K)

Type	Security	Shares	Price	Value
Sale	ACTG Common Stock F2	12,466	$4.57	$57K
Sale	ACTG Common Stock F1	20,534	$4.63	$95K

Holdings After Transaction: ACTG Common Stock — 254,655 shares (Direct)

Footnotes (2)

1. F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.615 to $4.645, inclusive. The Reporting Person undertakes to provide to Acacia Research Corporation ("Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form.
2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.51 to $4.66, inclusive. The Reporting Person undertakes to provide to Acacia Research Corporation ("Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form.

Key Figures

Total shares sold: 33,000 shares Shares sold September 2, 2026: 20,534 shares Weighted average price September 2, 2026: $4.63 per share +2 more

5 metrics

Total shares sold 33,000 shares Combined sales by the director on September 2–3, 2026

Shares sold September 2, 2026 20,534 shares Open market or private sales of ACTG common stock

Weighted average price September 2, 2026 $4.63 per share Multiple trades between $4.615 and $4.645

Shares sold September 3, 2026 12,466 shares Open market or private sales of ACTG common stock

Weighted average price September 3, 2026 $4.57 per share Multiple trades between $4.51 and $4.66

Key Terms

weighted average price, open market or private transaction, Rule 10b5-1

3 terms

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open market or private transaction financial

"Sale in open market or private transaction"

Rule 10b5-1 regulatory

"No Rule 10b5-1 trading plan is reported for these transactions"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

What insider transactions did ACTG disclose in this Form 4?

The filing reports that director Maureen O'Connell sold a total of 33,000 shares of ACACIA RESEARCH CORP common stock in open market or private transactions on September 2 and 3, 2026.

How many ACTG shares did the director sell on each date?

On September 2, 2026, the director sold 20,534 shares. On September 3, 2026, she sold 12,466 shares, for a combined total of 33,000 shares.

At what prices were the ACTG shares sold in this Form 4?

On September 2, the weighted average sale price was $4.63 per share, with individual trades between $4.615 and $4.645. On September 3, the weighted average price was $4.57, with trades between $4.51 and $4.66.

Was a Rule 10b5-1 trading plan used for the ACTG insider sales?

No. The Form 4 indicates that no Rule 10b5-1 trading plan was affirmed for these transactions, meaning the sales are not reported as occurring under a pre-arranged trading plan.

Does the Form 4 state how many ACTG shares the director owns after these sales?

No. For both reported transactions, the field for shares owned following the transaction is left blank, so the director's remaining ACTG holdings are not disclosed in this filing.

Are the reported ACTG sale prices exact or averages?

The prices shown, $4.63 and $4.57, are weighted average prices. Footnotes explain the shares were sold in multiple trades within specified price ranges on each date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/04/2026 - 04:01 PM Accepted by SEC EDGAR 09/04/2026 - 04:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

OCONNELL MAUREEN

(Last) (First) (Middle)

777 THIRD AVENUE

SUITE 2602

(Street)

NEW YORK NEW YORK 10017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ACACIA RESEARCH CORP [ ACTG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
ACTG Common Stock	09/02/2026		S		20,534	D	$4.63(1)	267,121	D
ACTG Common Stock	09/03/2026		S		12,466	D	$4.57(2)	254,655	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.615 to $4.645, inclusive. The Reporting Person undertakes to provide to Acacia Research Corporation ("Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.51 to $4.66, inclusive. The Reporting Person undertakes to provide to Acacia Research Corporation ("Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form.

Remarks:

	Jennifer Graff, Attorney-in-fact	09/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)